tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185

CanSino Biologics, Inc. Class H (6185) Revenue

Compare
4 Followers

CanSino Biologics, Inc. Class H Revenue

CanSino Biologics, Inc. Class H had a revenue of 338.98M in the quarter ending Sep 30, 2025, with 38.27%. This bring the company's revenue in the last twelve months to 1.00B, Decreased 8.14%. In the fiscal year ending Dec 31, 2024, CanSino Biologics, Inc. Class H had annual revenue of 846.34M with 145.19% growth.
Revenue (ttm)
1.00B
Revenue Growth
29.21%
P/S Ratio
15.30
Revenue/Employee
HK$765,917
Employees
1,105
Market Cap
HK$12.95B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
846.34M501.16M+245.19%
Dec 31, 2023
345.18M-685.86M+33.48%
Dec 31, 2022
1.03B-3.27B+23.98%
Dec 31, 2021
4.30B4.27B+17,274.82%
Dec 31, 2020
24.89M22.61M+1,090.05%
Dec 31, 2019
2.28M1.15M+201.71%
Dec 31, 2018
1.13M-8.05M+12.33%
Dec 31, 2017
9.18M987.00K+112.04%
Dec 31, 2016
8.20M